Kovitz Investment Group Partners’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $27.5M | Sell |
115,869
-3,680
| -3% | -$765K | 0.61% | 40 |
|
|
2026
Q1 | $25.3M | Sell |
119,549
-16,475
| -12% | -$3.55M | 0.59% | 42 |
|
|
2025
Q4 | $28M | Sell |
136,024
-100,481
| -42% | -$18.9M | 0.62% | 35 |
|
|
2025
Q3 | $37.1M | Buy |
236,505
+165,080
| +231% | +$25.5M | 0.14% | 133 |
|
|
2025
Q2 | $12M | Buy |
71,425
+16,960
| +31% | +$2.52M | 0.05% | 277 |
|
|
2025
Q1 | $7.5M | Buy |
54,465
+157
| +0.3% | +$20K | 0.04% | 323 |
|
|
2024
Q4 | $6.42M | Sell |
54,308
-15,551
| -22% | -$1.82M | 0.03% | 352 |
|
|
2024
Q3 | $7.11M | Buy |
69,859
+19,187
| +38% | +$2.01M | 0.05% | 289 |
|
|
2024
Q2 | $4.98M | Sell |
50,672
-1,848
| -4% | -$188K | 0.04% | 291 |
|
|
2024
Q1 | $5.88M | Buy |
52,520
+1,793
| +4% | +$193K | 0.07% | 187 |
|
|
2023
Q4 | $5.11M | Sell |
50,727
-13,558
| -21% | -$1.35M | 0.08% | 148 |
|
|
2023
Q3 | $5.58M | Sell |
64,285
-1,768
| -3% | -$160K | 0.1% | 122 |
|
|
2023
Q2 | $6.25M | Sell |
66,053
-5,005
| -7% | -$423K | 0.09% | 113 |
|
|
2023
Q1 | $5.37M | Sell |
71,058
-3,369
| -5% | -$254K | 0.09% | 143 |
|
|
2022
Q4 | $5.72M | Sell |
74,427
-6,343
| -8% | -$482K | 0.11% | 139 |
|
|
2022
Q3 | $5.39M | Sell |
80,770
-1,328
| -2% | -$84.2K | 0.12% | 129 |
|
|
2022
Q2 | $4.29M | Buy |
82,098
+74
| +0.1% | +$4.21K | 0.1% | 171 |
|
|
2022
Q1 | $4.65M | Buy |
82,024
+27,790
| +51% | +$1.49M | 0.09% | 171 |
|
|
2021
Q4 | $2.9M | Sell |
54,234
-18,731
| -26% | -$919K | 0.07% | 177 |
|
|
2021
Q3 | $3.61M | Buy |
72,965
+9,635
| +15% | +$523K | 0.07% | 181 |
|
|
2021
Q2 | $3.62M | Buy |
63,330
+6,905
| +12% | +$403K | 0.07% | 189 |
|
|
2021
Q1 | $3.43M | Buy |
56,425
+2,191
| +4% | +$121K | 0.08% | 169 |
|
|
2020
Q4 | $2.9M | Buy |
54,234
+948
| +2% | +$49.2K | 0.07% | 173 |
|
|
2020
Q3 | $2.5M | Buy |
53,286
+305
| +0.6% | +$15.7K | 0.07% | 171 |
|
|
2020
Q2 | $2.77M | Sell |
52,981
-2,093
| -4% | -$108K | 0.09% | 153 |
|
|
2020
Q1 | $2.64M | Buy |
55,074
+863
| +2% | +$44.8K | 0.1% | 146 |
|
|
2019
Q4 | $2.74M | Buy |
54,211
+301
| +0.6% | +$15.5K | 0.08% | 169 |
|
|
2019
Q3 | $2.54M | Sell |
53,910
-322
| -0.6% | -$14.7K | 0.08% | 176 |
|
|
2019
Q2 | $2.55M | Sell |
54,232
-2,974
| -5% | -$137K | 0.08% | 170 |
|
|
2019
Q1 | $2.75M | Buy |
57,206
+1,110
| +2% | +$55.6K | 0.09% | 161 |
|
|
2018
Q4 | $2.5M | Buy |
+56,096
| New | +$2.92M | 0.1% | 127 |
|
Other funds holding CAH
Kovitz Investment Group Partners's CAH Position: Q2 2026 in Review
Kovitz Investment Group Partners reduced its Cardinal Health (CAH) stake by 3.1% in Q2 2026, selling an estimated $765K and leaving 115,869 shares worth $27.5M. The position accounts for 0.61% of the portfolio, ranked #40.
Kovitz Investment Group Partners first reported a position in CAH in Q4 2018 and has held it in 31 quarters since. The position peaked at $37.1M in Q3 2025. 1,495 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Kovitz Investment Group Partners held 115,869 shares of Cardinal Health worth $27.5M as of Q2 2026.
- Kovitz Investment Group Partners sold 3,680 Cardinal Health shares in Q2 2026, an estimated $765K.
- Cardinal Health made up 0.61% of Kovitz Investment Group Partners's portfolio in Q2 2026, its #40 holding.
- Kovitz Investment Group Partners first reported a position in Cardinal Health in Q4 2018 and has held it in 31 quarters since.
- Kovitz Investment Group Partners's Cardinal Health position peaked at $37.1M in Q3 2025.
- 1,495 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Kovitz Investment Group Partners's 13F filing for Q2 2026, filed 12 Aug 2026.